Search

Displaying results 8601 - 8610 of 10000 in total
  1. Drug

    Serdemetan

    go.drugbank.com/drugs/DB12027
    Investigational

    Serdemetan has been used in trials studying the treatment of Neoplasms.

  2. Drug

    Cordycepin

    go.drugbank.com/drugs/DB12156
    Investigational

    Cordycepin has been used in trials studying the treatment of Leukemia.

  3. Drug

    Zicronapine

    go.drugbank.com/drugs/DB12188
    Investigational

    Zicronapine has been used in trials studying the treatment of Schizophrenia.

  4. Drug

    Selurampanel

    go.drugbank.com/drugs/DB12367
    Investigational

    Selurampanel has been investigated in Adrenocortical Adenoma and Sarcoma, Endometrial Stromal.

  5. Drug

    Intetumumab

    go.drugbank.com/drugs/DB12701
    Investigational

    Intetumumab has been used in trials studying the treatment of Melanoma.

  6. Drug

    Flizasertib

    go.drugbank.com/drugs/DB21613
    Investigational

    Flizasertib is under investigation in clinical trial NCT06602453 (A Study to Evaluate the Efficacy and Safety of GDC-8264 in Preventing Cardiac Surgery-Associated Acute Kidney Injury (AKI) and Major Adverse … The usage of the INN stem '-sertib' in the name indicates that Flizasertib is a serine/threonine kinase inhibitor.

  7. Drug

    Amenamevir

    go.drugbank.com/drugs/DB11701
    Investigational

    Amenamevir has been used in trials studying the treatment of Herpes Zoster, Herpes Simplex, Herpes Genitalis, and Safety of Amenamevir.

  8. Drug

    Florbenazine F-18

    go.drugbank.com/drugs/DB14945
    Investigational

    Florbenazine F-18 is under investigation in clinical trial NCT01515384 (A Trial of 18F-AV-133 Positron Emission Tomography (PET)).

  9. Drug

    Iodine I-131 monoclonal antibody 81C6

    go.drugbank.com/drugs/DB16197
    Investigational

    Neuradiab is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).

  10. Drug

    Sibofimloc

    go.drugbank.com/drugs/DB16400
    Investigational

    Sibofimloc is under investigation in clinical trial NCT03943446 (TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD)).